scispace - formally typeset
K

Kwang Yu Chang

Researcher at National Cheng Kung University

Publications -  30
Citations -  840

Kwang Yu Chang is an academic researcher from National Cheng Kung University. The author has contributed to research in topics: Temozolomide & Cancer research. The author has an hindex of 14, co-authored 24 publications receiving 661 citations. Previous affiliations of Kwang Yu Chang include National Health Research Institutes.

Papers
More filters
Journal ArticleDOI

Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo

TL;DR: Data indicate that NVP-BGT226 is a potential drug in the treatment of head and neck cancer, and results of the terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling (TUNEL) assay indicated that BGT226 induced cancer cell death through an apoptosis-independent pathway.
Journal ArticleDOI

Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma.

TL;DR: It is found that HBx deregulates TSC1/mTOR signaling through IKKβ, which is crucially linked to HBV-associated HCC development, and higher pIKK β, pTSC1, and pS6K1 levels were correlated with a poor prognosis in patients.